-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lidocaine in Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Lidocaine in Interstitial Cystitis (Painful Bladder Syndrome/Bladder Pain Syndrome)Drug Details:Lidocaine (ALV-107) is under development for the...